Clinical Trial Update: A Double-blind, Placebo-controlled Study of Antidepressant Augmentation With Agomelatine [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind, placebo-controlled trial evaluated augmentation with agomelatine in adults with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Agomelatine (agomelatine)

Snippet

Sponsor: Central South University | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED